CH42682035 analysis
Key facts
Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and Rest of World. The was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.